期刊文献+

微小剂量卡维地洛防治大鼠急性心肌梗死左室重构的实验研究 被引量:1

Experimental study on efficacy of very low-dose carvedilol in preventing left ventricular remodeling after acute myocardial infarction in rats
下载PDF
导出
摘要 目的 探讨微小剂量卡维地洛对大鼠急性心肌梗死 (AMI)左室重构的防治作用。方法 采用Olivetti的方法对 130只雌性SD大鼠致AMI,随机分成AMI和卡维地洛微小剂量组。另设假手术对照组。给药 4周后行血流动力学测定和病理分析。结果 AMI组与假手术组相比 ,左室舒张末压 (LVEDP)、容积 (LVV)、重量 (LVW )均显著增加(P均 <0 .0 0 1) ,左室内压最大上升和下降速率 (±dp/dp)及其校正值 (±dp/dt/LVSP)均显著降低 (P <0 .0 1~0 .0 0 1)。卡维地洛组与AMI组相比 ,LVEDP、LVV和LVW均显著降低 (P均 <0 .0 1) ,±dp/dt及±dp/dt/LVSP均显著增加 (P <0 .0 5 ~ 0 .0 1)。结论 卡维地洛微小剂量即能有效防止大鼠AMI左室重构 。 Objective To evaluate the efficacy of very low dose carvedilol in preventing left ventricular remodeling(LVRM) after acute myocardial infarction(AMI) in rats.Methods AMI model was made in 130 SD rats by the methods of Olivetti.The surviving rats were randomly assigned to AMI control and very low dose carvedilol groups.Sham operated rats were selected randomly.After Four weeks of therapy,hemodynamic studies and pathologic analysis were performed.After excluding the rats with infarct size<35% or >55%,34 rats were left,which comprised AMI(n=11), very low dose carvedilol(n=11) and Sham operated (n=12) groups.Results Compared with sham operated group,left ventricular(LV) end diastolic pressure(LVEDP),volume(LVV) and weight(LVW) were all significantly increased(all P<0.001), while LV pressure maximal rate of rise and fall(±dp/dt) as well as their corrected values(±dp/dt/LVSP) were all significantly decreased(P<0.01~0.001) in AMI group.In comparison with AMI group,the LVEDP,LVV and LVW were significantly decreased(all P<0.001), while ±dp/dt and ±dp/dt/LVSP were significantly increased(all P< 0.01) in very low dose carvedilol group,indicating that carvedilol at very low dose is effective.Conclusions Carvedilol at very low dose can prevent LV remodeling,improve hemodynamics and LV function after AMI in rats.
出处 《中华老年心脑血管病杂志》 CAS 2001年第5期334-337,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 卡维地洛 心肌梗塞 左室重构 血流动力学 carvedilol myocardial infarction left ventricular remodeling rat
  • 相关文献

参考文献11

  • 1Doughty RN.Whalley CA.Gamble G.et al.Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disase[J].J Am coll Cardiol.1997.29:1060-1066
  • 2Senior R.Basu S.Kinsey C.et al.Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction [J].Am Herat J.1999.137:646-652.
  • 3Bristow MR.Cilbert EM,Abraham WT.et al.Carvedilol produced doserelated improvements in left ventricular function and sruvival in subjects with chronic heart failure[J].Circulation.1996.94:2807-2816.
  • 4Olivetti G.Capasso JM,Meggs LG.et al.Cellular basis of chronic ventricular remodeling after mycoardial infarction in rats[J].Cir Res.1991.68:856-859.
  • 5Litwin SE,Katz S.Long term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction[J].J Am Coll Cardiol.1996.28:773-781.
  • 6Kai Hu Gaudron P.Georg E.et al.Long-term effects of beta-adrenergic blocking agent treatment of hemodynamic funcation and left ventricular remodeling in rats with expreimental myocardial infarction[J].J Am Coll Cardiol.1998.31:692-700.
  • 7Packer M,Bristow MR.Cohn J.et al US Heart failure Study Group:the effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J].N Engl J Med.1996.334:1349-1355.
  • 8Zamchetti A.Stalla A.Neural control of renin release[J].Clin Sci Mol Med.1975.48:215-223.
  • 9Vaughan DE.Pfeffer MA.ACEI and cardiovascular remodeling[J].Cardiovasc Res.1994.28:159-165.
  • 10Capornolla S.Febo O.Gnemmi M.et al.β-blockade therpay in chronic heart failure:diastolic function and mitral regurgitation improvement by cervedilol[J].Am Heart J.2000.139:596-608.

同被引文献17

  • 1Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest, 1996,74(1):86-107.
  • 2Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res, 1996,226(2):316-327.
  • 3Yue TL, Wang C, Romanic AM, et al. Staurosporine-induced apoptosis in cardiomyocytes: A potential role of Cas pase-3. J Mol Cell Cardiol, 1998,30(3):495-507.
  • 4Yang YJ, Tang YD, Ruan YM, et al. Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in rats. Circ J, 2003,67(2):159-162.
  • 5Weisman HF BD, Mannisi JA, Weisfeldt ML,et al. Cellular mechanisms of myocardial infarct expansion. Circulation, 1988,78(1):186-201.
  • 6Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res, 1985,57(1):84-95.
  • 7Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest, 1997,100(6):1363-1372.
  • 8Sam F, Sawyer DB, Chang DL, et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol, 2000,279(1):H422-428.
  • 9Cheng W LB, Kajstura J, Li P, et al. Stretch-induced programmed myocyte cell death. J Clin Invest, 1995,96(5):2247-2259.
  • 10Li WG, Zaheer A, Coppey L, et al. Activation of JNK in the remote myocardium after large myocardial infarction in rats. Biochem Biophys Res Commun, 1998,246(3):816-820.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部